Agilent Expands Cross-Vendor CDS Instrument Control
03 January 2020 - 12:00AM
Business Wire
New software extends the company’s compatibility strategy
Agilent Technologies Inc. (NYSE: A) today announced the latest
implementation of its mutual compatibility philosophy. Now, joint
customers of Agilent Technologies and Thermo Fisher Scientific can
choose a chromatography data system from either company—Agilent
OpenLab CDS or Thermo Fisher Chromeleon—to control analytical
instruments from both organizations.
The two companies recognize that reliable multivendor instrument
control is critical to the successful operation of today’s
analytical laboratories. Using a single data system increases lab
productivity by saving substantial time managing software, training
staff, and making it easier to meet the regulations that govern the
lab.
“Agilent's multivendor control approach to laboratory
informatics allows our customers to select the best hardware and
software for their needs,” said John Sadler, vice president and
general manager of Agilent's Software and Informatics Division.
“That is why we invest in integrating third-party analytical
instruments into our OpenLab software suite, in collaboration with
other analytical instrument manufacturers. Our goal is to provide
simple and complete support for our mutual customers.”
Agilent OpenLab CDS streamlines laboratory operations with a
single, secure data system that combines chromatography and mass
spectrometry into one software platform. OpenLab CDS is a
multivendor platform controlling Agilent GC, LC, single quadrupole
GC/MS, LC/MS instruments along with many other instrument
vendors.
Thermo Fisher Scientific instrument families are the latest
additions to OpenLab CDS multivendor control program. OpenLab CDS
tools provide time-saving steps in the analysis, interpretation,
and reporting workflows, enabling users to quickly identify key
information, improve turnaround time, and ensure the highest level
of data integrity.
“The lack of interoperability between different vendors’
instruments and software has traditionally presented a barrier to
laboratories adopting the right solutions to meet the unique needs
of their workflows,” said Matt Hazlewood, senior director, global
enterprise chromatography data systems, at Thermo Fisher
Scientific. “The renewal of our commitment with Agilent for mutual
compatibility and third-party control of instruments ensures that
customers will have continued access to our market-leading
Chromeleon CDS software platform, meaning they can deploy the
analytical solutions they need without compromising the flexibility
or efficiency of their workflows.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in life
sciences, diagnostics and applied chemical markets. Now in its 20th
year as an independent company delivering insight and innovation
toward improving the quality of life, Agilent instruments,
software, services, solutions, and people provide trusted answers
to customers' most challenging questions. The company generated
revenue of $5.16 billion in fiscal 2019 and employs 16,300 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, subscribe to
the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and
Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200102005121/en/
Naomi Goumillout Agilent Technologies +1.781.266.2819
naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2024 to May 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From May 2023 to May 2024